These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 35910702)

  • 1. Remdesivir-Induced Extreme Sinus Bradycardia in COVID-19.
    Wasef N; Hamilton S; Fatima T; Osgood E
    Cureus; 2022 Jul; 14(7):e27307. PubMed ID: 35910702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remdesivir associated sinus bradycardia in patients with COVID-19: A prospective longitudinal study.
    Hajimoradi M; Sharif Kashani B; Dastan F; Aghdasi S; Abedini A; Naghashzadeh F; Mohamadifar A; Keshmiri MS; Noorali S; Lookzadeh S; Alizadeh N; Siri MA; Tavasolpanahi M; Abdolmohammadi Y; Shafaghi M; Rouhani ZS; Shafaghi S
    Front Pharmacol; 2022; 13():1107198. PubMed ID: 36733376
    [No Abstract]   [Full Text] [Related]  

  • 3. Remdesivir therapy causing bradycardia in COVID-19 patients: Two case reports.
    Abdelmajid A; Osman W; Musa H; Elhiday H; Munir W; Al Maslamani MA; Elmekaty EZ
    IDCases; 2021; 26():e01254. PubMed ID: 34401329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sinus Bradycardia Associated with Remdesivir Treatment in COVID-19: A Case Report and Literature Review.
    Barkas F; Styla CP; Bechlioulis A; Milionis H; Liberopoulos E
    J Cardiovasc Dev Dis; 2021 Feb; 8(2):. PubMed ID: 33673216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remdesivir-induced Bradycardia is not Associated with Worse Outcome in Patients with COVID-19: A Retrospective Analysis.
    Pantazopoulos I; Mavrovounis G; Dimeas G; Zikos N; Pitsikou M; Rousogianni E; Mermiri M; Michou A; Spanos M; Maniotis C; Chalkias A; Laou E; Zakynthinos G; Chatzis D; Gourgoulianis K
    Am J Cardiovasc Drugs; 2022 Nov; 22(6):705-710. PubMed ID: 36002783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remdesivir-Induced Marked Sinus Bradycardia in COVID-19.
    Ahmed T; Lodhi SH; Ahmed T
    Cureus; 2022 Jul; 14(7):e27249. PubMed ID: 36035063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remdesivir-induced bradycardia in a 26-year-old patient with COVID-19: a case report.
    Guziejko K; Talalaj J; Chorazy M; Groth M; Moniuszko-Malinowska A
    Infection; 2022 Dec; 50(6):1605-1613. PubMed ID: 35701724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and potential risk factors for remdesivir-associated bradycardia in hospitalized patients with COVID-19: A retrospective cohort study.
    Alsowaida YS; Shehadeh F; Kalligeros M; Mylonakis E
    Front Pharmacol; 2023; 14():1106044. PubMed ID: 36817161
    [No Abstract]   [Full Text] [Related]  

  • 9. Precipitating factors of bradycardia after remdesivir administration: ICU admission and cutoff value for declining heart rate.
    Chen YZ; Lin MS; Lin YP; Liu YZ; Yang CJ
    J Microbiol Immunol Infect; 2023 Oct; 56(5):970-976. PubMed ID: 37407291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Permanent Pacemaker Placement Secondary to Remdesivir Induced Bradycardia: A Case Report.
    Khan S; Mustafa A; Elhosseiny SM; Rizvi T; Lafferty J
    Cureus; 2022 Oct; 14(10):e30923. PubMed ID: 36465748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Bradycardia Following Remdesivir Administration Through the US Food and Drug Administration American College of Medical Toxicology COVID-19 Toxic Pharmacovigilance Project.
    Devgun JM; Zhang R; Brent J; Wax P; Burkhart K; Meyn A; Campleman S; Abston S; Aldy K;
    JAMA Netw Open; 2023 Feb; 6(2):e2255815. PubMed ID: 36787141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remdesivir-Associated Sinus Arrest in COVID-19: A Potential Indication for Close Cardiac Monitoring.
    Gregory GE; Gregory HM; Liaqat H; Ghaly MM; Johnson-Pich KD
    Cureus; 2022 Feb; 14(2):e22328. PubMed ID: 35317046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remdesivir-Associated Significant Bradycardia: A Report of Three Cases.
    Shirvani M; Sayad B; Shojaei L; Amini A; Shahbazi F
    J Tehran Heart Cent; 2021 Apr; 16(2):79-83. PubMed ID: 35082876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complete heart block associated with Remdesivir in COVID-19: a case report.
    Selvaraj V; Bavishi C; Patel S; Dapaah-Afriyie K
    Eur Heart J Case Rep; 2021 Jul; 5(7):ytab200. PubMed ID: 34222786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transient asymptomatic bradycardia and remdesivir in COVID-19 patients.
    Adamo G; Amata M; Cannizzaro N; Chessari C; Sapienza GM; Capizzi GM; Battaglia S; Benfante A; Scichilone N
    Minerva Med; 2023 Aug; 114(4):463-468. PubMed ID: 35332758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bradycardia and Outcomes in COVID-19 Patients on Remdesivir: A Multicenter Retrospective Study.
    Umeh CA; Maguwudze S; Kaur H; Dimowo O; Naderi N; Safdarpour A; Hussein T; Gupta R
    Cardiol Res; 2023 Jun; 14(3):192-200. PubMed ID: 37304919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remdesivir-associated bradycardia in COVID-19: a rapid review protocol.
    Tian E; Cosme C; Bauzon J; Batra K; Azar F; Schreiber A
    BMJ Open; 2023 May; 13(5):e068564. PubMed ID: 37258075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serious bradycardia and remdesivir for coronavirus 2019 (COVID-19): a new safety concerns.
    Touafchia A; Bagheri H; Carrié D; Durrieu G; Sommet A; Chouchana L; Montastruc F
    Clin Microbiol Infect; 2021 Feb; 27(5):791.e5-8. PubMed ID: 33647441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bradycardia Related to Remdesivir During COVID-19: Persistent or Permanent?
    Maheshwari M; Athiraman H
    Cureus; 2021 Nov; 13(11):e19919. PubMed ID: 34956798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remdesivir-Induced Bradycardia.
    Kanagala SG; Dholiya H; Jhajj P; Patel MA; Gupta V; Gupta S; Wu SI; Jain R
    South Med J; 2023 Mar; 116(3):317-320. PubMed ID: 36863055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.